Login / Signup

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.

Antonin VaryLoïc LebellecFrédéric Di FioreNicolas PenelClaire CheymolEmilia RadFarid El HajbiAstrid LièvreJulien EdelineAndré Michel BimbaiMarie-Cécile Le DeleyAnthony Turpin
Published in: Therapeutic advances in medical oncology (2021)
Pragmatic dose adjustments of FOLFIRINOX should be made by oncologists without considering a loss of effect.
Keyphrases
  • locally advanced
  • study protocol
  • rectal cancer
  • squamous cell carcinoma
  • randomized controlled trial
  • radiation therapy
  • clinical trial
  • advanced cancer